Form 4: Twist Bioscience CEO Emily Leproust Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Emily Leproust, CEO of Twist Bioscience, sold 1,114 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

  • On July 2, 2024, Emily M. Leproust, CEO of Twist Bioscience, sold 1,114 shares of Twist Bioscience Corp (TWST) common stock at a price of $48.002 per share.
  • The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
  • Following the transaction, Leproust directly owns 504,732 shares of Twist Bioscience Corp.
  • Leproust also holds various employee stock options with exercise prices ranging from $5.95 to $67.85, and expiration dates ranging from 2025 to 2030.
  • These options represent the right to buy a total of 637,918 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, as it simply reports facts.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This filing indicates that the CEO is selling shares to cover tax obligations, which is a common practice.

Stakeholder Impact

  • The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

DateDescription
09/01/201625% of shares subject to one employee stock option vested.
09/28/201710% of shares subject to one employee stock option vested.
09/28/201815% of shares subject to one employee stock option vested.
10/31/201920% of shares subject to one employee stock option vested.
10/24/202025% of shares subject to one employee stock option vested.
09/01/2020Performance stock options granted to the reporting person.
12/19/2022Performance stock options vested and became exercisable.
07/02/2024Emily Leproust sold 1,114 shares of TWST common stock.
07/05/2024Date of Form 4 filing.
09/28/2025Expiration date of one employee stock option.
09/28/2027Expiration date of one employee stock option.
11/18/2028Expiration date of one employee stock option.
10/23/2029Expiration date of one employee stock option.
08/31/2030Expiration date of one employee stock option.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.